<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>07640137341589</udiDi>
    <basicUdiDi>764013734sCD38HG</basicUdiDi>
    <tradeName>Grifols sCD38</tradeName>
    <deviceName>Grifols sCD38</deviceName>
    <manufacturerName>Medion Grifols Diagnostics AG</manufacturerName>
    <manufacturerSrn>CH-MF-000024272</manufacturerSrn>
    <authorisedRepresentativeName>Diagnostic Grifols, S.A.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000001573</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030399</emdnCode>
    <emdnDescription>IMMUNOHAEMATOLOGY  (BLOOD GROUPING) TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>213686</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-03T03:25:37.434Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640137341107</udiDi>
    <basicUdiDi>764013734Albumin-002CW</basicUdiDi>
    <tradeName>Specific Albumin 30%</tradeName>
    <deviceName>Specific Albumin 30%</deviceName>
    <manufacturerName>Medion Grifols Diagnostics AG</manufacturerName>
    <manufacturerSrn>CH-MF-000024272</manufacturerSrn>
    <authorisedRepresentativeName>Diagnostic Grifols, S.A.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000001573</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103030306</emdnCode>
    <emdnDescription>ENHANCEMENT MEDIA (E.G. BOVINE ALBUMIN, LISS, PEG)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>213573</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-03T03:25:22.092Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640137341084</udiDi>
    <basicUdiDi>764013734Albumin-001CU</basicUdiDi>
    <tradeName>Specific Albumin 22%</tradeName>
    <deviceName>Specific Albumin 22%</deviceName>
    <manufacturerName>Medion Grifols Diagnostics AG</manufacturerName>
    <manufacturerSrn>CH-MF-000024272</manufacturerSrn>
    <authorisedRepresentativeName>Diagnostic Grifols, S.A.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000001573</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103030306</emdnCode>
    <emdnDescription>ENHANCEMENT MEDIA (E.G. BOVINE ALBUMIN, LISS, PEG)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>213422</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-03T03:25:21.278Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640137341077</udiDi>
    <basicUdiDi>764013734Enlisst-IIMH</basicUdiDi>
    <tradeName>Enlisst-II</tradeName>
    <deviceName>Enlisst-II</deviceName>
    <manufacturerName>Medion Grifols Diagnostics AG</manufacturerName>
    <manufacturerSrn>CH-MF-000024272</manufacturerSrn>
    <authorisedRepresentativeName>Diagnostic Grifols, S.A.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000001573</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103030306</emdnCode>
    <emdnDescription>ENHANCEMENT MEDIA (E.G. BOVINE ALBUMIN, LISS, PEG)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>213577</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-03T03:25:20.501Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640137340681</udiDi>
    <basicUdiDi>764013734Bromelase305Z</basicUdiDi>
    <tradeName>Bromelase 30</tradeName>
    <deviceName>Bromelase 30</deviceName>
    <manufacturerName>Medion Grifols Diagnostics AG</manufacturerName>
    <manufacturerSrn>CH-MF-000024272</manufacturerSrn>
    <authorisedRepresentativeName>Diagnostic Grifols, S.A.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000001573</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103030307</emdnCode>
    <emdnDescription>ENZYMES (E.G. BROMELIN / PAPAIN, ETC.)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>213578</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-03T03:25:19.710Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640137340957</udiDi>
    <basicUdiDi>B-07640137340957</basicUdiDi>
    <tradeName>Anti-Lua</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medion Grifols Diagnostics AG</manufacturerName>
    <manufacturerSrn>CH-MF-000024272</manufacturerSrn>
    <authorisedRepresentativeName>Diagnostic Grifols, S.A.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000001573</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>213553</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:55:14.923Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640137341145</udiDi>
    <basicUdiDi>B-07640137341145</basicUdiDi>
    <tradeName>Neutr-AB II</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medion Grifols Diagnostics AG</manufacturerName>
    <manufacturerSrn>CH-MF-000024272</manufacturerSrn>
    <authorisedRepresentativeName>Diagnostic Grifols, S.A.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000001573</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>213424</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:55:14.847Z</lastUpdated>
  </row>
</eudamedExport>